ArticleJCO precision oncology2024

Next-Generation Sequencing-Guided Treatment of BRCA2-Mutant Metastatic Uterine Leiomyosarcoma With Poly(ADP-ribose) Polymerase Inhibitor Therapy.

Cameron Kirkendoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.